ETS1_NN
transactivates_VBZ
the_DT
human_JJ
GM-CSF_NN
promoter_NN
in_IN
Jurkat_NN
T_NN
cells_NNS
stimulated_VBN
with_IN
PMA_NN
and_CC
ionomycin_NN
._.

Activation_NN
of_IN
T_NN
helper_NN
cells_NNS
results_VBZ
in_IN
coordinate_JJ
expression_NN
of_IN
a_DT
number_NN
of_IN
cytokines_NNS
involved_VBN
in_IN
differentiation_NN
,_,
proliferation_NN
and_CC
activation_NN
of_IN
the_DT
hematopoietic_JJ
system_NN
._.

Granulocyte-macrophage_JJ
colony-stimulating_JJ
factor_NN
-LRB-_-LRB-
GM-CSF_NN
-RRB-_-RRB-
is_VBZ
one_CD
such_JJ
cytokine_NN
whose_WP$
increased_VBN
expression_NN
results_VBZ
partly_RB
from_IN
increases_NNS
in_IN
transcription_NN
._.

Cis-acting_JJ
elements_NNS
with_IN
NF_NN
kappa_NN
B_NN
,_,
AP-1_NN
and_CC
ETS-like_JJ
motifs_NNS
have_VBP
been_VBN
identified_VBN
in_IN
the_DT
promoter_NN
region_NN
of_IN
the_DT
GM-CSF_NN
gene_NN
,_,
which_WDT
are_VBP
important_JJ
for_IN
transcriptional_JJ
activity_NN
following_VBG
PMA_NN
and_CC
ionomycin_NN
stimulation_NN
._.

A_DT
number_NN
of_IN
the_DT
ETS_NN
family_NN
of_IN
transcription_NN
factors_NNS
are_VBP
expressed_VBN
in_IN
T_NN
cells_NNS
,_,
including_VBG
ETS1_NN
and_CC
ELF1_NN
._.

Here_RB
we_PRP
describe_VBP
the_DT
ability_NN
of_IN
these_DT
factors_NNS
to_TO
interact_VB
with_IN
a_DT
site_NN
-LRB-_-LRB-
GM5_NN
-RRB-_-RRB-
,_,
located_JJ
within_IN
the_DT
CLE0_NN
element_NN
,_,
-47_CD
to_TO
-40_CD
upstream_RB
of_IN
the_DT
GM-CSF_NN
transcription_NN
initiation_NN
site_NN
._.

Exogenous_JJ
ETS1_NN
,_,
but_CC
not_RB
ELF1_NN
,_,
can_MD
transactivate_VB
GM-CSF_NN
,_,
through_IN
the_DT
GM5_NN
site_NN
,_,
in_IN
a_DT
PMA_NN
\/_CC
ionomycin_NN
dependent_JJ
manner_NN
._.

Other_JJ
unidentified_JJ
ETS-like_JJ
factors_NNS
present_JJ
in_IN
Jurkat_NN
cells_NNS
are_VBP
also_RB
capable_JJ
of_IN
binding_NN
GM5_NN
._.

Mutation_NN
of_IN
the_DT
core_NN
ETS_NN
binding_NN
site_NN
from_IN
-_:
GGAA_NN
-_:
to_TO
-_:
GGAT_JJ
-_:
prevents_VBZ
the_DT
binding_NN
of_IN
ETS-like_JJ
factors_NNS
with_IN
the_DT
exception_NN
of_IN
ETS1_NN
._.

The_DT
GM-CSF_NN
promoter_NN
,_,
modified_VBN
in_IN
this_DT
way_NN
to_TO
be_VB
ETS1_NN
specific_JJ
,_,
is_VBZ
fully_RB
responsive_JJ
to_TO
PMA_NN
\/_:
ionomycin_NN
induction_NN
,_,
in_IN
addition_NN
to_TO
ETS1_NN
transactivation_NN
in_IN
the_DT
presence_NN
of_IN
PMA_NN
and_CC
ionomycin_NN
._.

Together_RB
these_DT
data_NNS
suggest_VBP
that_IN
ETS1_NN
may_MD
be_VB
involved_VBN
in_IN
mediating_VBG
the_DT
increased_VBN
GM-CSF_NN
production_NN
associated_VBN
with_IN
T_NN
cell_NN
activation_NN
._.

